コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 heteroaromatic systems commonly used in the pharmaceutical industry.
2 al approaches that are currently used in the pharmaceutical industry.
3 ne in the creativity and productivity of the pharmaceutical industry.
4 ely studied drug discovery target within the pharmaceutical industry.
5 drug discovery is a thriving strategy in the pharmaceutical industry.
6 ntly an area of significant interest for the pharmaceutical industry.
7 his challenge are highly sought after by the pharmaceutical industry.
8 exploit this neutral biopolymer in food and pharmaceutical industry.
9 pharmaceuticals and to save resources in the pharmaceutical industry.
10 y potential applications in the agrifood and pharmaceutical industry.
11 , consequently, are of great interest in the pharmaceutical industry.
12 nsiderable interest in both academia and the pharmaceutical industry.
13 on of enantiopure lactones or esters used in pharmaceutical industry.
14 ning protein 4, a prominent cancer target in pharmaceutical industry.
15 ents one of the major antitarget concerns in pharmaceutical industry.
16 a recipient of wastewater effluents from the pharmaceutical industry.
17 can produce glycoconjugates relevant to the pharmaceutical industry.
18 dered this the fastest growing sector in the pharmaceutical industry.
19 ators on US clinical trials sponsored by the pharmaceutical industry.
20 rent real-world separation problems from the pharmaceutical industry.
21 of processes and products, primarily in the pharmaceutical industry.
22 s (APIs) manipulated and/or produced in this pharmaceutical industry.
23 d the standard technologies employed by, the pharmaceutical industry.
24 ine materials is a principle interest of the pharmaceutical industry.
25 ct that could be of interest for food and/or pharmaceutical industry.
26 st important classes of drug targets for the pharmaceutical industry.
27 y intermediates in organic synthesis and the pharmaceutical industry.
28 amines are valuable building blocks for the pharmaceutical industry.
29 he manufacturing and marketing skills of the pharmaceutical industry.
30 zed solids is of significant interest in the pharmaceutical industry.
31 were unlikely to be developed further by the pharmaceutical industry.
32 libraries are an integral element in today's pharmaceutical industry.
33 g discovery from Western governments and the pharmaceutical industry.
34 ug discovery and development programs in the pharmaceutical industry.
35 al, patients, government regulators, and the pharmaceutical industry.
36 us agents, and remain the 'workhorse' of the pharmaceutical industry.
37 nvestment are stifling antibiotic R&D in the pharmaceutical industry.
38 clodextrins are well-known excipients in the pharmaceutical industry.
39 as material science, agro chemistry, and the pharmaceutical industry.
40 ltimately yield widespread acceptance in the pharmaceutical industry.
41 ore become an indispensable procedure in the pharmaceutical industry.
42 tment in antimicrobial drug discovery by the pharmaceutical industry.
43 good practice" and "traceability" within the pharmaceutical industry.
44 ins is an important area of research for the pharmaceutical industry.
45 ns is of intense interest, especially to the pharmaceutical industry.
46 as again become an attractive target for the pharmaceutical industry.
47 nd selective inhibitor design for use in the pharmaceutical industry.
48 formation has created new challenges for the pharmaceutical industry.
49 having an enormous impact on research in the pharmaceutical industry.
50 re signalling the start of a new era for the pharmaceutical industry.
51 loyed in high-throughput applications in the pharmaceutical industry.
52 s well within the acceptance criteria of the pharmaceutical industry.
53 e inhibitors remains a high priority for the pharmaceutical industry.
54 university-based clinical scientists and the pharmaceutical industry.
55 try (HDX-MS) is increasingly utilized in the pharmaceutical industry.
56 gists received substantial payments from the pharmaceutical industry.
57 cial relationship between physicians and the pharmaceutical industry.
58 t but immensely worthwhile challenge for the pharmaceutical industry.
59 enting important class types relevant to the pharmaceutical industry.
60 GPCRs have been successfully targeted by the pharmaceutical industry.
61 resented separately given its large, generic pharmaceutical industry.
62 stion of major practical significance in the pharmaceutical industry.
63 ch and preclinical toxicity screening by the pharmaceutical industry.
64 ves as a novel potential drug target for the pharmaceutical industry.
65 es, which are of significant interest in the pharmaceutical industry.
66 therapeutic areas is of key interest to the pharmaceutical industry.
67 uccess, delivering blockbuster sales for the pharmaceutical industry.
68 es is becoming increasingly important in the pharmaceutical industry.
69 sent, therefore, an important target for the pharmaceutical industry.
70 in therapeutics are rapidly transforming the pharmaceutical industry.
71 locks for bioactive compounds as well as the pharmaceutical industry.
72 he individual, the healthcare system and the pharmaceutical industry.
73 e considered as attractive scaffolds for the pharmaceutical industry.
74 ration in several materials for the food and pharmaceutical industries.
75 for their applications in food, cosmetic and pharmaceutical industries.
76 ducts are of interest in food, cosmetics and pharmaceutical industries.
77 crobial sanitation technologies for food and pharmaceutical industries.
78 hen extracted and used in food, cosmetic and pharmaceutical industries.
79 me of increasing importance for chemical and pharmaceutical industries.
80 A prices due to negotiation between BMoH and pharmaceutical industries.
81 moting antioxidants for use by both food and pharmaceutical industries.
82 find applications in the food, cosmetic and pharmaceutical industries.
83 ol synthesis is critical to the chemical and pharmaceutical industries.
84 based products in both the biotechnology and pharmaceutical industries.
85 Extracts could be used in the food and pharmaceutical industries.
86 c protein could be used in food, cosmetic or pharmaceutical industries.
87 as useful colorants in the nutraceutical and pharmaceutical industries.
88 on and collaboration between the tobacco and pharmaceutical industries.
89 ive substance in the food, nutraceutical and pharmaceutical industries.
90 y-products to recover compounds for food and pharmaceutical industries.
91 several end-users in the food, cosmetic and pharmaceutical industries.
92 C-N bonds, which are of high interest to the pharmaceutical industries.
93 o the petroleum, materials, agricultural and pharmaceutical industries.
94 able biomass in the food, feed, chemical and pharmaceutical industries.
95 nd theoretical interest for the chemical and pharmaceutical industries.
96 rch in academia and in the biotechnology and pharmaceutical industries.
97 at potential for application in the food and pharmaceutical industries.
98 d for cryoEM to become widely interesting to pharmaceutical industries.
99 urces, has many applications in the food and pharmaceutical industries.
100 s, that could be of interest in the food and pharmaceutical industries.
101 sources of antioxidants for use in food and pharmaceutical industries.
102 parts of durian fruits can benefit food and pharmaceutical industries.
103 ase in the developing world, and also on the pharmaceutical industry?
104 anging market pressures being applied to the pharmaceutical industry, a greater emphasis is being mad
105 n of subject matter experts representing the pharmaceutical industry, academia, product development p
106 practitioners, regulatory agencies, and the pharmaceutical industry aggressively seek biomarkers to
108 tform chemical in the food, agriculture, and pharmaceutical industries and is mainly biosynthesized b
109 d collaborates with the oral health care and pharmaceutical industries and medical PBRNs to advance t
110 overy of valuable metabolites in biorefinery pharmaceutical industries and the disinfection of large-
111 ed separately because it has a large generic pharmaceutical industry and a higher availability of med
112 plains the increasing engagement of both the pharmaceutical industry and academia towards the discove
115 There has been little consensus between the pharmaceutical industry and academic communities concern
116 natorial chemistry is now commonplace in the pharmaceutical industry and applied rigorously in the di
120 It must be borne in mind, however, that the pharmaceutical industry and hospital budgetary restricti
123 Drug Administration provides guidance to the pharmaceutical industry and others designing randomized
124 l focus on the current challenges facing the pharmaceutical industry and Pharma's responses to addres
125 l focus on the current challenges facing the pharmaceutical industry and Pharma's responses, focusing
126 cientific community, in partnership with the pharmaceutical industry and public organizations, has fa
127 drug metabolism and pharmacokinetics for the pharmaceutical industry and regulatory authorities, and
128 se has received considerable interest in the pharmaceutical industry and remains a valid and interest
129 the criticisms that have been leveled at the pharmaceutical industry and summarize the supporting dat
132 issues have not encouraged investment by the pharmaceutical industry and there have been no new licen
133 nhance the clinical relationship between the pharmaceutical industry and those involved with organ tr
134 d the globe, and it provides peptides to the pharmaceutical industry and to thousands of scientists w
135 omoted to the general population by both the pharmaceutical industry and tobacco control advocates.
136 hed in 2010 between the COPD Foundation, the pharmaceutical industry, and academic chronic obstructiv
137 reported some type of relationship with the pharmaceutical industry, and most of these relationships
138 prised of representatives from academia, the pharmaceutical industry, and the federal government incl
140 ve limited exposure to how the biotechnology/pharmaceutical industry approaches drug discovery and de
141 e know that clinical trials sponsored by the pharmaceutical industry are likely to exaggerate benefit
142 accuracy.Traditional approaches used in the pharmaceutical industry are not precise or versatile eno
144 l protein targets under investigation in the pharmaceutical industry are protein or lipid kinases.
147 ls, and therefore, it can be of interest for pharmaceutical industries as a high-throughput BBB penet
148 ansplant clinicians, transplant researchers, pharmaceutical industries as well as regulatory organiza
149 ost a decade, TRPV1 has been explored by the pharmaceutical industry as a potential target for exampl
150 beta-HSD1) has been widely considered by the pharmaceutical industry as a target to treat metabolic s
151 atients, there is a basic problem facing the pharmaceutical industry as it tries to balance the conun
152 nt for drug discovery and development in the pharmaceutical industry, as well as for a variety of oth
154 lic peptides are promising scaffolds for the pharmaceutical industry but their chemical synthesis is
155 ply imposed on the medical profession by the pharmaceutical industry but was developed through the in
158 lthcare professionals at all levels, and the pharmaceutical industry can this grim outlook for liver
159 logical and drug development activity by the pharmaceutical industry, compounds derived from two key
161 The role played by organic chemistry in the pharmaceutical industry continues to be one of the main
162 s produced by mammalian cell cultures in the pharmaceutical industry continues to increase, the need
163 emerged as a powerful synthetic tool in the pharmaceutical industry, contributing to the manufacturi
168 tantial increases in research funding by the pharmaceutical industry, drug discovery rates seem to ha
169 clinical and translational researchers, the pharmaceutical industry, drug regulators, and patients a
170 n the agricultural, food, personal care, and pharmaceutical industries due to their cost effectivenes
171 rom soil bacteria and are of interest in the pharmaceutical industry due to their potent activity aga
172 get of intensive research efforts across the pharmaceutical industry, due to its potential for the tr
173 e than three decades of intense research and pharmaceutical industry efforts, a clinically effective
174 2013, assembled academic, public health and pharmaceutical industry experts to assess the challenges
175 old" solid-state chemistry fields, as in the pharmaceutical industry field, where they represent a wa
176 ble interest from the medical community, the pharmaceutical industry, financial markets, and regulato
178 Encapsulation is an important technology for pharmaceutical industry, food production, et cetera.
179 is a technique attractive for use within the pharmaceutical industry for at-line determination of res
180 ses the required detection limits set by the pharmaceutical industry for HZ detection in the presence
181 n shown to be a powerful strategy within the pharmaceutical industry for increasing throughput while
185 achieve the required detection limits by the pharmaceutical industry for the detection of HZ in the p
186 alysis has become an important method in the pharmaceutical industry for the incorporation of new fun
187 nsiderable attention from clinicians and the pharmaceutical industry for the management of hyperchole
189 tively pursued as therapeutic targets in the pharmaceutical industry for the treatment of a variety o
190 to cover an underfunded PRO effort (eg, the pharmaceutical industry, foundations, or National Instit
191 ded, while maintaining independence from the pharmaceutical industry funding sources in the reporting
193 e proteins as drug targets, and although the pharmaceutical industry has been focusing on these recep
194 validation of novel pipeline targets of the pharmaceutical industry has been provided using mouse kn
195 of interest and scientific momentum, as the pharmaceutical industry has come to appreciate the role
200 global delivery of novel treatments from the pharmaceutical industry has plunged to the level of the
202 he basis of compelling genetic evidence, the pharmaceutical industry has put a large emphasis on brai
204 valence and enormous unmet medical need, the pharmaceutical industry has recently de-emphasized neuro
211 ll inevitably increase dramatically, and the pharmaceutical industry, healthcare providers, patient a
212 razine (HZ) is of critical importance in the pharmaceutical industry in order to uphold drug safety.
216 peptides, has attracted the interest of the pharmaceutical industry in these molecules as potential
225 In his new book Ben Goldacre argues that the pharmaceutical industry is in poor health and in urgent
226 st 384 wells), it is becoming clear that the pharmaceutical industry is now routinely running cell-ba
228 es more popular, a major implication for the pharmaceutical industry is that studies should be conduc
230 -federal, academic, foundational, and in the pharmaceutical industry--is needed to meet these challen
231 arch: the National Institutes of Health, the pharmaceutical industry, large biotechnology firms, and
233 e increasingly widespread use throughout the pharmaceutical industry, mechanistic detail about the in
234 rs, funding agencies, ethics committees, the pharmaceutical industry, medical journals, and governmen
235 ents; professional bodies; academia; and the pharmaceutical industry met to review the current state
236 )-antihistamines currently available and the pharmaceutical industries need to keep developing H(1)-a
237 activity (similar to a primary screen in the pharmaceutical industry) or to measure memory (habituati
239 the criticisms that have been leveled at the pharmaceutical industry over the past 3 decades and summ
241 latiramer acetate (GA, Cop-1; Copaxone; Teva Pharmaceutical Industries, Pitach Tikva, Israel) has bee
242 velopment of new antimicrobial agents in the pharmaceutical industry poses unanticipated challenges i
243 s at diagnosis and relapse; a joint academic-pharmaceutical industry preclinical platform to help ana
248 , uncertainties have persisted regarding the pharmaceutical industry's conventionally accepted approa
250 asic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and
252 federal agencies, lay organizations, and the pharmaceutical industry should consider the taskforce's
254 linical and recently marketed drugs from the pharmaceutical industry showed that all have the same co
255 s, clinicians, health care providers and the pharmaceutical industry so that we continue the pathway
257 (range: 1735 to 15,699) were required for a pharmaceutical industry-sponsored trial involving 20 sub
259 entional Trials) guideline authors (n = 16), pharmaceutical industry statisticians (n = 3), journal e
260 mong the FDA, academia, data owners, and the pharmaceutical industry that is responding to the need t
261 losure of clinical trials are similar to the pharmaceutical industries, the iterative nature of devic
262 tient cohorts, and growing interest from the pharmaceutical industry, the field is poised to make a b
263 lishment and sustained growth of the steroid pharmaceutical industry, the production of highly functi
264 tocol for cFAE and its widespread use in the pharmaceutical industry, the reaction mechanism has not
266 addition to formulations manufactured by the pharmaceutical industry, there has been a recent interes
269 idant peptides of high interest for food and pharmaceutical industries to develop new nutraceuticals
270 rugs is considered by decision-makers in the pharmaceutical industry to be the most appealing route o
271 ty crisis in drug discovery has prompted the pharmaceutical industry to decentralize R&D, which is no
272 Despite very significant efforts by the pharmaceutical industry to develop drugs, with over 50 s
273 tcomes but has catalyzed the interest in the pharmaceutical industry to develop the next generation o
274 itally important for both basic research and pharmaceutical industry to establish a high throughput t
275 us, considerable efforts are underway in the pharmaceutical industry to find drugs to treat this cond
276 Considerable efforts are being spent in the pharmaceutical industry to identify therapeutic approach
277 e cyclic oligosaccharides widely used in the pharmaceutical industry to improve drug delivery and to
278 edicinal chemistry teams in academia and the pharmaceutical industry to improve potency, physicochemi
279 ced in the USA and Europe that encourage the pharmaceutical industry to invest in targets that might
280 lative change, substantial incentives to the pharmaceutical industry to invest in the ultra-rare dise
284 lders (patients, clinicians, methodologists, pharmaceutical industry) to determine core outcome domai
285 put screening campaigns,in particular in the pharmaceutical industry, to make the most out of the rec
286 alidity is often poor, particularly for some pharmaceutical industry trials, a perception that has le
287 Serono, Bayer Schering Pharmaceuticals, Teva Pharmaceuticals Industries, UK National Institute of Hea
289 onsiderable application, particularly in the pharmaceutical industry where there is growing awareness
290 ions, therefore, are of high interest to the pharmaceutical industry, where lead compounds in drug de
291 applications in multiple areas including the pharmaceutical industry, where Raman spectroscopy is com
292 containing molecules has proliferated in the pharmaceutical industry, where the incorporation of halo
293 attrition rates of lead compounds within the pharmaceutical industry, which are often a result of scr
294 of dramatic variability in response, and the pharmaceutical industry, which must develop new drugs de
295 sms are currently under consideration in the pharmaceutical industry, which will hopefully result in
296 enges that the research, the clinic, and the pharmaceutical industry will face in developing efficien
297 ational effort by cancer researchers and the pharmaceutical industry will help to further develop thi
299 ryonic development, as well as providing the pharmaceutical industry with an economical bioreactor.
300 s one of the highest growing segments of the pharmaceutical industry with an estimated global market
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。